Immunic IMUX
NASDAQ IMUX
$7.22 -0.26 (-3.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immunic (IMUX) Short-term Investments (2022 - 2023)

Updated

Immunic (IMUX) posted Short-term Investments of $4.4 million for Q1 2023, down 54.3% from the prior quarter.

Analysis

Immunic (IMUX) Short-term Investments (2022 - 2023) Analysis & Trends

At the end of FY2022, Immunic's Short-term Investments came in at $9.63 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Immunic 302.70 Mn -89.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 4.40 Mn
Dec 31, 2022 9.63 Mn
API Access

Immunic Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=IMUX&period=max&api_key=YOUR_API_KEY